NASDAQ: ASBP
Aspire Biopharma Holdings Inc Stock Ownership - Who owns Aspire Biopharma Holdings?

Insider buying vs selling

Have Aspire Biopharma Holdings Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ASBP insiders and whales buy or sell their stock.

ASBP Shareholders

What type of owners hold Aspire Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Surendra K. Ajjarapu8.72%4,317,500$1.08MInsider
Powerup Sponsor LLC5.79%2,870,000$717.50kInsider
Toronto Dominion Bank1.04%516,845$129.21kInstitution
Crewe Advisors LLC0.63%313,427$78.36kInstitution
Harraden Circle Investments LLC0.30%150,000$37.50kInstitution
Optivise Advisory Services LLC0.21%106,446$26.61kInstitution
Procyon Advisors LLC0.20%98,500$24.63kInstitution
Periscope Capital Inc0.15%75,000$18.75kInstitution
Platform Technology Partners0.08%37,611$9.40kInstitution
Ubs Group Ag0.06%29,945$7.49kInstitution

1 of 2

ASBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASBP2.90%14.51%
INAB23.88%25.77%Net BuyingNet Buying
BRTX0.27%99.73%Net Selling
CLRB11.30%8.96%Net Buying
HOTH2.31%57.47%Net Buying

Aspire Biopharma Holdings Stock Ownership FAQ

Who owns Aspire Biopharma Holdings?

Aspire Biopharma Holdings (NASDAQ: ASBP) is owned by 2.90% institutional shareholders, 14.51% Aspire Biopharma Holdings insiders, and 82.59% retail investors. Surendra K. Ajjarapu is the largest individual Aspire Biopharma Holdings shareholder, owning 4.32M shares representing 8.72% of the company. Surendra K. Ajjarapu's Aspire Biopharma Holdings shares are currently valued at $1.04M.

If you're new to stock investing, here's how to buy Aspire Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.